Evidence map›Paper›PMID 40749333›Full record

ReviewPharmacological reviews2025

Neuropeptides as transmitters and regulators of the locus coeruleus noradrenergic system.

Léa J Becker, Madison M Martin, Alex C Hughes, Bernard Mulvey, Chao-Cheng Kuo, Sean C Piantadosi, Michael R Bruchas, Keri Martinowich, Frank J Meye, Lindsay A Schwarz and 3 more

Abstract readReview
In one paragraph

Review in Pharmacological reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Léa J BeckerDepartment of Anesthesiology, Washington University in St. Louis, St. Louis, Missouri; Center for Clinical Pharmacology, Washington University School of Medicine, St. Louis, Missouri; Washington University Pain Center, Washington University in St. Louis, St. Louis, Missouri.
Madison M MartinDepartment of Anesthesiology and Pain Medicine and Department of Pharmacology, Center for the Neurobiology of Addiction, Pain and Emotion, University of Washington, Seattle, Washington.
Alex C HughesDepartment of Medical Oncology, University of Colorado Anschutz, Aurora, Colorado.
Bernard MulveyLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, Maryland; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland.
Chao-Cheng KuoDepartment of Anesthesiology, Washington University in St. Louis, St. Louis, Missouri; Center for Clinical Pharmacology, Washington University School of Medicine, St. Louis, Missouri; Washington University Pain Center, Washington University in St. Louis, St. Louis, Missouri.
Sean C PiantadosiDepartment of Anesthesiology and Pain Medicine and Department of Pharmacology, Center for the Neurobiology of Addiction, Pain and Emotion, University of Washington, Seattle, Washington.
Michael R BruchasDepartment of Anesthesiology and Pain Medicine and Department of Pharmacology, Center for the Neurobiology of Addiction, Pain and Emotion, University of Washington, Seattle, Washington.
Keri MartinowichLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, Maryland; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland; The Solomon H. Snyder Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, Maryland; Johns Hopkins Kavli Neuroscience Discovery Institute, Baltimore, Maryland.
Frank J MeyeDepartment of Translational Neuroscience, Brain Center, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.
Lindsay A SchwarzDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee.
David WeinshenkerDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
Jordan G McCallDepartment of Anesthesiology, Washington University in St. Louis, St. Louis, Missouri; Center for Clinical Pharmacology, Washington University School of Medicine, St. Louis, Missouri; Washington University Pain Center, Washington University in St. Louis, St. Louis, Missouri.
Danai RigaDepartment of Human Genetics, Amsterdam University Medical Center (VUmc), Amsterdam, The Netherlands; Department of Functional Genomics, Center for Neurogenomics and Cognitive Research (CNCR), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. Electronic address: d.riga2@vu.nl.

Funding

INTERDISCIPLINARY TRAINING PROGRAM IN NEUROSCIENCEST32MH015330 · NIMH · JOHNS HOPKINS UNIVERSITY · PI MARGOLIS, RUSSELL L · 1985 to 2024
$6.2M
Decoding Locus Coeruleus Neural Circuits and Signaling In Negative AffectR01MH112355 · NIMH · WASHINGTON UNIVERSITY · PI Michael R. Bruchas · 2016 to 2026
$5.3M
Impact of neuromelanin and Tau accumulation during aging and disease on local gene expression in the human locus coeruleus using spatially-resolved transcriptomics with protein detectionR01AG085933 · NIA · LIEBER INSTITUTE, INC. · PI Stephanie Carinne Hicks, Keri Martinowich · 2024 to 2026
$2.5M
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcementR01DA049257 · NIDA · EMORY UNIVERSITY · PI WEINSHENKER, DAVID · 2020 to 2024
$2.3M
Validation of electrophysiological biomarkers associated with performance in a preclinical assay of sustained attentionR01MH137057 · NIMH · LIEBER INSTITUTE, INC. · PI Gregory V Carr, Keri Martinowich · 2024 to 2026
$2.3M
Stress-induced plasticity in noradrenergic analgesiaR01NS117899 · NINDS · WASHINGTON UNIVERSITY · PI MCCALL, JORDAN G. · 2020 to 2024
$1.9M
Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's diseaseRF1AG079199 · NIA · EMORY UNIVERSITY · PI WEINSHENKER, DAVID · 2022 to 2024
$1.6M
Endogenous opioid regulation of locus coeruleus-mediated analgesiaR01NS135401 · NINDS · WASHINGTON UNIVERSITY · PI Ream Al-Hasani, Jordan G. McCall · 2024 to 2026
$1.5M
Contribution of neuromelanin to selective vulnerability of locus coeruleus neurons in Alzheimer's diseaseR01AG079199 · NIA · EMORY UNIVERSITY · PI DAVID WEINSHENKER · 2025 to 2026
$1.0M
Molecular, cellular and physiological correlates of sustained attention in the locus coeruleus to anterior cingulate cortex circuitR21MH130066 · NIMH · LIEBER INSTITUTE, INC. · PI HALLOCK, HENRY L, MARTINOWICH, KERI · 2023 to 2023
$444k
Characterizing the function of locus coeruleus and pericoerulear zone activity during avoidance behaviorF31MH136670 · NIMH · UNIVERSITY OF WASHINGTON · PI Madison Margaret Martin · 2024 to 2026
$149k
NIA NIH HHS R01 AG079199NIA NIH HHS R01 AG085933NIA NIH HHS RF1 AG079199NIDA NIH HHS R01 DA049257NIMH NIH HHS F31 MH136670NIMH NIH HHS R01 MH112355NIMH NIH HHS R01 MH137057NIMH NIH HHS R21 MH130066NIMH NIH HHS T32 MH015330NINDS NIH HHS R01 NS117899NINDS NIH HHS R01 NS135401
6 · The paper itself

Abstract

The locus coeruleus (LC), the brain's main source of noradrenaline, has received increased attention due to the recently unveiled heterogeneity of its cell types. Departing from the long-standing idea of molecular, anatomical, and functional uniformity of the structure, we now understand the LC as a multiplexed nucleus, capable of temporally precise and targeted neuromodulation of distinct brain regions and functions. The LC neuropeptidergic landscape provides a window into this remarkable neuronal diversity. Stemming from recent technological advances that have allowed for LC transcriptional profiling, a wealth of data on the (co)expression of LC neuropeptides and their cognate receptors has come to light. Peptidergic systems are ideally situated to exert neuromodulatory control over the LC noradrenergic system. This peptidergic control can occur both locally, within the LC and the neighboring peri-LC microcircuitry, and at distal LC terminal fields. The functional significance of LC neuropeptidergic signaling in physiological processes and pathological conditions is an emerging field. Here we compile existing literature on the expression, anatomical distribution, physiological effects, and, when available, behavioral role of the major neuropeptidergic populations of, and innervating, the LC and peri-LC. Furthermore, we highlight current methodologies that delineate LC peptidergic input/output, aiming at uncovering their functional role. Finally, we discuss how neuropeptidergic signaling enables LC modularity and thus sustains a multifaceted role of physiological noradrenaline release dynamics with a rich feature set of behavioral representations. SIGNIFICANCE STATEMENT: The locus coeruleus (LC) noradrenergic system influences a variety of neurophysiological processes to coordinate complex behaviors. These far-reaching neuromodulatory effects are not solely mediated by noradrenaline, but rather, by a variety of coreleased neuropeptides that can alter postsynaptic responses in LC terminal regions. In addition, the LC itself is regulated by a multitude of incoming peptidergic signals that drive wide-ranging changes in LC neuronal physiology and the subsequent patterns of noradrenaline release. It is important to understand how neuropeptide (co)transmitters and regulators of the LC can drive circuit-level plasticity and adaptive behavioral responses to changing environmental stimuli. This review compiles our current understanding of these processes, providing additionally crucial insights into the mechanisms underlying LC dysfunction and its many related neuropsychiatric conditions.

Indexed as

Adrenergic NeuronsLocus CoeruleusNeuropeptidesNeurotransmitter AgentsNorepinephrineAnimalsHumansNeuropeptidesNeurotransmitter AgentsNorepinephrine

Identifiers

PMID40749333
PMCPMC12799466

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.